Abbot
A USA company, Abbott, has received authorization from the U.S. Food and Drug Administration for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes.
What makes this test so different is where it can be used: outside the four walls of a traditional hospital such as in the physicians’ office or urgent care clinics.
The test runs on a lightweight box (6.6 pounds and the size of a small toaster) that can sit in a variety of locations.
Because of its small size, it can be used in more non-traditional places where people can have their results in a matter of minutes.
They are ramping up production to deliver 50,000 ID NOW COVID-19 tests per day, beginning next week, to the U.S. healthcare system.
“Through the incredible work of teams across Abbott, we expect to deliver 50,000 COVID-19 tests per day to healthcare professionals on the front lines, where testing capabilities are needed most,” said Chris Scoggins, senior vice president, Rapid Diagnostics, Abbott.
You may be interested
Orban’s Lyon Face Provisional Relegation To Ligue 2 Amid Financial Woes
Webby - November 15, 2024Olympique Lyon the club of Nigerian striker Gift Orban, have been handed a provisional Ligue 1 relegation by theDNCG who…
Ghana Miss Out On AFCON 2025 Qualification After Draw With Angola
Webby - November 15, 2024Black Stars of Ghana’s hopes of qualifying for next year’s AFCON was ended after they played a 1-1 draw away…
‘It Was A Fair Result’ — Troost-Ekong Reacts To Super Eagles Stalemate Vs Benin Republic
Webby - November 15, 2024Super Eagles captain William Troost-Ekong claimed the Super Eagles deserved a point from their 2025 Africa Cup of Nations qualifying…